Skip to main content
profile image
Selected Works of John M. Pagel, MD, PhD
Article
Safety of idelalisib in B-cell malignancies: Integrated analysis of eight clinical trials.
Journal of Clinical Oncology (2017)
  • Steven Coutre, Stanford University
  • Jacqueline Claudia Barrientos, Hofstra University
  • Jennifer R. Brown, Harvard University
  • Sven De Vos, University of California, Los Angeles
  • Richard R. Furman, NewYork–Presbyterian Hospital
  • Michael J. Keating, University of Texas MD Anderson Cancer Center
  • Susan Mary O'Brien, Queen Mary University of London
  • John M. Pagel, Cancer Institute
  • Jeff Porter Sharman, Cancer Institute
  • Andrew David Zelenetz, Memorial Sloan Kettering Cancer Center
  • Terry Newcomb
  • Yoonjin Cho
  • Christopher Aguilar
  • Lyndah Dreiling, Amgen
Link
Disciplines
Publication Date
January 31, 2017
Citation Information
Steven Coutre, Jacqueline Claudia Barrientos, Jennifer R. Brown, Sven De Vos, et al.. "Safety of idelalisib in B-cell malignancies: Integrated analysis of eight clinical trials." Journal of Clinical Oncology (2017)
Available at: http://works.bepress.com/john-pagel/15/